has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 45.8498 crores during the period ended September 30, 2021 as compared to Rs. 49.5439 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 4.4769 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 4.4942 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 7.78 for the period ended September 30, 2021 as compared to Rs. 7.81 for the period ended June 30, 2021.
Total Income | ₹ 45.8498 crs | ₹49.5439 crs | -7.46% |
Net Profit | ₹4.4769 crs | ₹4.4942 crs | -0.38% |
EPS | ₹7.78 | ₹7.81 | -0.38% |
Financial Results (Q2 FY2022) - YoY Comparison The company has reported total income of Rs. 45.8498 crores during the period ended September 30, 2021 as compared to Rs.43.8951 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.4.4769 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.2.3743 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.7.78 for the period ended September 30, 2021 as compared to Rs.0.20 for the period ended September 30, 2020.
Total Income | ₹ 45.8498 crs | ₹43.8951 crs | 4.45% |
Net Profit | ₹4.4769 crs | ₹2.3743 crs | 88.56% |
EPS | ₹7.78 | ₹0.20 | 3,790.00% |
Financial Results (Half Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.95.3937 crores during the 6 Months period ended September 30, 2021 as compared to Rs.80.0725 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.8.9711 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.3.8736 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.0.75 for the 6 Months period ended September 30, 2021 as compared to Rs.0.33 for the 6 Months period ended September 30, 2020.
Total Income | ₹95.3937 crs | ₹80.0725 crs | 19.13% |
Net Profit | ₹8.9711 crs | ₹3.8736 crs | 131.60% |
EPS | ₹0.75 | ₹0.33 | 127.27% |
Source : Equity Bulls
Keywords
SharonBioMedicine
Q2FY22
H1FY22
ResultUpdate